Latest letter from Corcept to Susan D. Wigenton | CORT Message Board Posts

Corcept Therapeutics Inc

  CORT website

  • LIMITED OFFER

    30% off Bronze Patron packages
    (reduced from
    $250 to $175)
    * includes 2 yrs of Premium Plus service
    * lock in 30% discount on future upgrades


    Only 13 left!

CORT   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  2924 of 3003  at  1/17/2020 10:06:17 AM  by

Leverage01


Latest letter from Corcept to Susan D. Wigenton

Here is some bit of news regarding the court case.

On July 26, 2019 CORT informed Teva that it was no longer asserting infringement of the '526, '242, and '243 patents.

It makes sense as those patents were almost all of them related to the same purported invention. Same as the '348 patent for which Neptune Generics filed an IPR last August 2018 and for which a final decision is due in February 2020. It seems that CORT expects the IPR to be instituted (hopefully the stock will not drop another 30%) and if so, it could easily invalidate '526, '242, and '243 patents and help Teva.

So nothing ground breaking but thought it would be interesting to know.

Also the debut of the Markman hearing is set for the Fifth of March.

GL to All.


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 0     Views: 116
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board






About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2019 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...